Literature DB >> 10855462

A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia.

A Schuld1, M Kühn, M Haack, T Kraus, D Hinze-Selch, C Lechner, T Pollmächer.   

Abstract

Clozapine is known to induce epileptic seizures and changes in EEG-patterns, including slowing and the appearance of epileptiform activity. Olanzapine, a new antipsychotic drug, shares many pharmacological and clinical properties with clozapine. However, in patients treated with olanzapine, no case of seizure induction has been reported so far, and the EEG has not been studied systematically. We examined the EEGs of patients with schizophrenia treated with either olanzapine (N = 9) or clozapine (N = 9) prior to medication and 3 to 7 weeks afterwards. Clozapine induced significant EEG slowing present in 78% of the patients, and definite epileptiform activity appeared in 33%. Olanzapine also induced significant EEG slowing, but less frequently (in 44% of the patients) and less pronounced than clozapine. Olanzapine had no significant effect an epileptiform activity, but in one patient, an isolated sharp/slow-wave complex was observed. These preliminary data suggest that olanzapine induces EEG slowing to a lower extent than clozapine. Olanzapine's possible effect an the seizure threshold deserves further attention.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10855462     DOI: 10.1055/s-2000-7976

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  10 in total

1.  Olanzapine causes a leptin-dependent increase in acetylcholine release in mouse prefrontal cortex.

Authors:  Asheley B Wathen; Emily S West; Ralph Lydic; Helen A Baghdoyan
Journal:  Sleep       Date:  2012-03-01       Impact factor: 5.849

Review 2.  Effects of psychotropic drugs on seizure threshold.

Authors:  Francesco Pisani; Giancarla Oteri; Cinzia Costa; Giorgio Di Raimondo; Raoul Di Perri
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Clozapine versus other atypical antipsychotics for schizophrenia.

Authors:  Claudia Asenjo Lobos; Katja Komossa; Christine Rummel-Kluge; Heike Hunger; Franziska Schmid; Sandra Schwarz; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

4.  Clozapine-related EEG changes and seizures: dose and plasma-level relationships.

Authors:  Seema Varma; Delia Bishara; Frank M C Besag; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2011-04

Review 5.  Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management.

Authors:  Hesham Abboud; John Probasco; Sarosh R Irani; Beau Ances; David R Benavides; Michael Bradshaw; Paulo Pereira Christo; Russell C Dale; Mireya Fernandez-Fournier; Eoin P Flanagan; Avi Gadoth; Pravin George; Elena Grebenciucova; Adham Jammoul; Soon-Tae Lee; Yuebing Li; Marcelo Matiello; Anne Marie Morse; Alexander Rae-Grant; Galeno Rojas; Ian Rossman; Sarah Schmitt; Arun Venkatesan; Steven Vernino; Sean J Pittock; Maarten Titulaer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-01       Impact factor: 13.654

6.  EEG alterations during treatment with olanzapine.

Authors:  Detlef Degner; Michael A Nitsche; Frank Bias; Eckart Rüther; Udo Reulbach
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-23       Impact factor: 5.270

7.  Low-dose Clozapine-induced Seizure: A Case Report.

Authors:  Abdullah Bolu; Süleyman Akarsu; Erdal Pan; Emre Aydemir; Taner Oznur
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-05-31       Impact factor: 2.582

Review 8.  A Framework Proposal to Follow-Up on Preclinical Convulsive Signals of a New Molecular Entity in First-in-Human Studies Using Electroencephalographic Monitoring.

Authors:  Markus Abt; Theo Dinklo; Andreas Rothfuss; Elisabeth Husar; Robert Dannecker; Katja Kallivroussis; Richard Peck; Lucette Doessegger; Christoph Wandel
Journal:  Clin Pharmacol Ther       Date:  2019-05-31       Impact factor: 6.875

9.  Clozapine-induced seizure.

Authors:  Ankur Jyoti Borah; Abhijit Kalita; Satya Kumar Dutta
Journal:  Indian J Pharmacol       Date:  2020-01-16       Impact factor: 1.200

Review 10.  A Working Hypothesis Regarding Identical Pathomechanisms between Clinical Efficacy and Adverse Reaction of Clozapine via the Activation of Connexin43.

Authors:  Motohiro Okada; Kouji Fukuyama; Takashi Shiroyama; Masahiko Murata
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.